🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

North American Comfilcon A Clinical Study

Recruitingn/aAges 8 Years - 75 YearsAllCooperVision International Limited (CVIL)
NCT06902584 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age 8 to 75 years (inclusive). 2. Current wearer of the Comfilcon A sphere, toric, multifocal, toric multifocal or Energys contact lens for at least 12 months. 3. At least occasional overnight wear in the last 12 months. Exclusion Criteria: 1\. Current participation in a contact lens or contact lens care product clinical trial.
💊

What it tests

  • comfilcon A Sphere lens
  • comfilcon A Toric lens
  • comfilcon A Multifocal lens
  • comfilcon A Multifocal Toric lens
  • comfilcon A Energys lens
📍

Where

4 sites
University of Berkeley
Berkeley, United States
ProCare Vision Center
Granville, United States
Nittany Eye Associates
College, United States
Drs. McIntyre, Garza, Avila and Jurica, Optometrists
Corpus Christi, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy